Comparison on Asian Cancer Summit criteria and LI-RADS in diagnosis of hepatitis B inflammatory small hepatocellular carcinoma
10.13929/j.issn.1672-8475.2020.11.008
- VernacularTitle: 比较亚洲肿瘤峰会标准与LI-RADS对乙型肝炎性小肝癌的诊断价值
- Author:
Xiaoyu LIU
1
Author Information
1. Department of Radiology, The First Affiliated Hospital of Zhejiang University School of Medicine
- Publication Type:Journal Article
- Keywords:
Carcinoma, hepatocellular;
Diagnostic imaging;
Hepatitis B
- From:
Chinese Journal of Interventional Imaging and Therapy
2020;17(11):671-674
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To compare Asian Oncology Summit (AOS, 2016) criteria and liver imaging reporting and data system (LI-RADS) in diagnosis of hepatitis B inflammatory small hepatocellular carcinoma(sHCC). Methods: Upper abdominal CT and MR examination were performed in 130 patients with suspected hepatitis B inflammatory sHCC (172 hepatic nodules with diameters ≤30 mm). Taken pathological results as the gold standards, the sensitivity and specificity of AOS standard and LI-RADS for diagnosis of hepatitis B sHCC were calculated. Results: ①For lesions with diameter ≤30 mm, the sensitivity and specificity of AOS criteria was 55.00% (44/80) and 92.39% (85/92), while of Li-RADS grading criteria was 100% (80/80) and 67.39% (62/92), respectively. ②For lesions with diameter <20 mm, the sensitivity and specificity of AOS criteria was 40.00% (10/25) and 94.34% (50/53), of Li-RADS grading criteria was 100% (25/25) and 71.70% (38/53), respectively. Conclusion: LI-RADS was more sensitive in diagnosis of hepatitis B inflammatory sHCC than AOS criteria, being helpful to early diagnosis and treatment.
